C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 5/10 (2006.01) A61K 35/12 (2006.01) A61K 39/395 (2006.01) A61K 45/00 (2006.01) A61K 48/00 (2006.01) C07K 14/47 (2006.01) C07K 14/705 (2006.01) C07K 16/18 (2006.01) C07K 16/28 (2006.01) C12N 15/85 (2006.01) C12Q 1/00 (2006.01) C12Q 1/68 (2006.01) G01N 33/50 (2006.01) G01N 33/68 (2006.01) A01K 67/027 (2006.01) C12N 15/12 (2006.01)
Patent
CA 2610709
The present invention relates to transgenic animals, as well as compositions and methods relating to the characterization of gene function. Specifically, the present invention provides transgenic mice comprising disruptions in PRO69122, PRO204, PRO214, PRO222, PRO234, PRO265, PRO309, PRO332, PRO342, PRO356, PRO540, PRO618, PRO944, PRO994, PRO1079, PRO1110, PRO1122, PRO1138, PRO1190, PRO1272, PRO1286, PRO1295, PRO1309, PRO1316, PRO1383, PRO1384, PRO1431, PRO1434, PRO1475, PRO1481, PRO1568, PRO1573, PRO1599, PRO1604, PRO1605, PRO1693, PRO1753, PRO1755, PRO1777, PRO1788, PRO1864, PRO1925, PRO1926, PRO3566, PRO4330, PRO4423, PRO36935, PRO4977, PRO4979, PRO4980, PRO4981, PRO5801, PRO5995, PRO6001, PRO6095, PRO6182, PRO7170, PRO7171, PRO7436, PRO9912, PRO9917, PRO37337, PRO37496, PRO19646, PRO21718, PRO19820, PRO21201, PRO20026, PRO20110, PRO23203 or PRO35250 genes. Such in vivo studies and characterizations may provide valuable identification and discovery of therapeutics and/or treatments useful in the prevention, amelioration or correction of diseases or dysfunctions associated with gene disruptions such as neurological disorders; cardiovascular, endothelial or angiogenic disorders; eye abnormalities; immunological disorders; oncological disorders; bone metabolic abnormalities or disorders; lipid metabolic disorders; or developmental abnormalities.
La présente invention concerne des animaux transgéniques ainsi que des compositions et des procédés se rapportant à la caractérisation de la fonction génique. De manière plus spécifique, cette invention porte sur des souris transgéniques comprenant des disruptions dans les gènes PRO69122, PRO204, PRO214, PRO222, PRO234, PRO265, PRO309, PRO332, PRO342, PRO356, PRO540, PRO618, PRO944, PRO994, PRO1079, PRO1110, PRO1122, PRO1138, PRO1190, PRO1272, PRO1286, PRO1295, PRO1309, PRO1316, PRO1383, PRO1384, PRO1431, PRO1434, PRO1475, PRO1481, PRO1568, PRO1573, PRO1599, PRO1604, PRO1605, PRO1693, PRO1753, PRO1755, PRO1777, PRO1788, PRO1864, PRO1925, PRO1926, PRO3566, PRO4330, PRO4423, PRO36935, PRO4977, PRO4979, PRO4980, PRO4981, PRO5801, PRO5995, PRO6001, PRO6095, PRO6182, PRO7170, PRO7171, PRO7436, PRO9912, PRO9917, PRO37337, PRO37496, PRO19646, PRO21718, PRO19820, PRO21201, PRO20026, PRO20110, PRO23203 ou PRO35250. De telles études et caractérisations in vivo peuvent assurer une identification intéressante et la découverte de thérapies et/ou de traitements utiles dans la prévention, l'amélioration ou la correction de maladies et de dysfonctionnements associés aux disruptions géniques telles que les troubles neurologiques; les troubles cardio-vasculaires, endothéliaux ou angiogéniques; les anomalies de l'oeil; les troubles immunologiques; les troubles oncologiques; les anomalies ou les troubles du métabolisme osseux; les troubles du métabolisme des lipides; ou les troubles de la croissance.
Combs Katherin E.
Culbertson Ling Ling
Desauvage Frederic
Ding Zhiyong
Edwards Joel
Genentech Inc.
Lexicon Pharmaceuticals Inc.
Smart & Biggar
LandOfFree
Transgenic models for different genes and their use for gene... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Transgenic models for different genes and their use for gene..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transgenic models for different genes and their use for gene... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2004167